NCT03302195View on ClinicalTrials.gov

Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery

NARecruitingINTERVENTIONAL
Enrollment

410

Participants

Timeline

Start Date

August 21, 2015

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2027

Conditions
Cardiopulmonary BypassObesity
Interventions
DRUG

Heparin

Based on patient body weight (UI/kg)

PROCEDURE

cardiopulmonary bypass pump flow rate

Based on patient body weight (L/min/m2)

Trial Locations (1)

G1V 4G5

RECRUITING

Hopital Laval, Québec

All Listed Sponsors
collaborator

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

OTHER

lead

Laval University

OTHER